Clinical Trial Update: Expression of Molecular Markers in Circulating Tumor Cells of Metastatic Castration-Resistant Prostate Cancer

View source ↗

Summary

A clinical trial update examining expression of molecular markers in circulating tumor cells from patients with metastatic castration-resistant prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Snippet

Sponsor: Fudan University | Conditions: Prostate Cancer Metastatic | Status: UNKNOWN